The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How Rheumatologists Can Connect with Congressional Lawmakers during August Recess

How Rheumatologists Can Connect with Congressional Lawmakers during August Recess

June 1, 2014 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • How Rheumatologists Can Connect with Congress during August Recess
  • Congress’ District Workweeks in August Prime Time for Rheumatology Advocacy
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
Explore This Issue
June 2014
Also By This Author
  • Money Matters in Running a Rheumatology Practice

Members of Congress will spend the month of August working in their districts and meeting with constituents. With the November elections approaching quickly, members are particularly eager to meet with constituents. This is an ideal time to arrange a meeting at your lawmakers’ local district offices. This important opportunity allows you to educate lawmakers on the critical issues facing the rheumatology community and position yourself as a resource on future healthcare issues.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

August recess is scheduled for Aug. 4–Sept. 7. Lawmakers’ schedules fill up quickly, so planning ahead is important—July is the best time to request an August meeting.

In-person meetings are critical because they allow you to develop a personal relationship with your lawmakers and their staff. As you continue to grow this relationship, lawmakers will feel comfortable turning to you as a trusted resource on important healthcare issues.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

How Do I Schedule a Meeting in the Local Office?

Use the Legislative Action Center (http://www.rheumatology.org/actioncenter) on the ACR website to find your legislator’s contact information. When you call your lawmakers’ local office, a member of their staff will answer the phone. Identify yourself as a constituent and tell them that you would like to meet with the member during the August recess to discuss current legislative issues that affect your practice and your patients. The staff member will be happy to find a mutually convenient time for you to stop by.

What Issues Should I Discuss?

H.R. 460—the Patients’ Access to Treatments Act

Biologic drugs, such as those used to treat rheumatoid arthritis, psoriatic arthritis, lupus and other rheumatic diseases, are breakthrough treatments that often prevent disability, save and improve lives, and allow patients to function and remain in the workforce. Insurance plans are increasingly placing biologic drugs on specialty, requiring a percentage of the drug cost, preventing many patients from accessing these critical medications. H.R. 460, Introduced by Rep. David McKinley (R-W.Va.) and Rep. Lois Capps (D-Calif.), would limit cost sharing on specialty tiers to what plans require for nonpreferred brand drugs. Please ask members of the House of Representatives to cosponsor this legislation and ask senators to support companion legislation in the Senate.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

H.R. 1416—Protect Patient Access to In-Office Treatments

Sequestration cuts to Medicare payments went into effect April 1, 2013. The reductions are affecting reimbursement for both services and infusion drugs, effectively decreasing Part B drug reimbursement from ASP+6 to ASP+4.3. These cuts threaten the ability of rheumatologists to provide critical therapies to patients. Patients may be forced to seek the same treatment in the hospital setting, at a higher cost to patients and the system—and often with significant additional burdens. Rep. Renee Ellmers (R-N.C.) introduced H.R. 1416, which would exempt physician-administered drugs under Medicare part B from sequestration. Please ask members of the House of Representatives to cosponsor this legislation and ask senators to support companion legislation in the Senate.

Reverse Course on NIH Funding

Federally funded biomedical research creates jobs, invests in local economic growth, increases innovation, confirms the next generation of scientists, reduces healthcare costs and improves American health. NIH’s capacity to fund biomedical research continues to decline. The NIH budget in FY2013 was $29.15 billion, a 5% decrease from FY2012. Reduced funding threatens America’s status as the world’s leader in medical innovation and delays progress toward lifesaving research, better prevention strategies and new treatments for arthritis and rheumatic diseases. Further cuts in NIH support will only serve to worse the funding crisis and dissuade health professionals from choosing careers in research. Please ask lawmakers to push for $32 billion in NIH funding in the FY2015 Labor, Health and Human Services Appropriations bill.

What Other Opportunities Are There to Meet with My Lawmaker?

Inviting lawmakers to visit your office is a powerful way to demonstrate the important care you provide. It’s also an opportunity to show them how the decisions they make in Washington affect you and your patients. If you are interested in hosting a lawmaker at your office and would like assistance in arranging the visit, contact ACR Government Affairs staff at [email protected].

Pages: 1 2 | Single Page

Filed Under: Biologics & Biosimilars, Drug Updates, From the College, Legislation & Advocacy, Practice Management, Professional Topics, Quality Assurance/Improvement Tagged With: AC&R, Advocacy, American College of Rheumatology, Biologics, Congress, drug, Legislation, Lupus, Practice Management, Psoriatic Arthritis, Rheumatoid arthritis, rheumatolgistIssue: June 2014

You Might Also Like:
  • How Rheumatologists Can Connect with Congress during August Recess
  • Congress’ District Workweeks in August Prime Time for Rheumatology Advocacy
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • Congressional Lawmakers Every Rheumatologist Should Know

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)